BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8598264)

  • 1. [Primary immunoproliferative small intestinal disease].
    Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
    G E N; 1995; 49(3):238-42. PubMed ID: 8598264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we suppress the antigenic stimulus in IPSID for lifelong?
    Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
    Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
    Shih LY; Liaw SJ; Dunn P; Kuo TT
    J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from Albania.
    Economidou I; Manousos ON; Triantafillidis JK; Vaslamatzis MM; Zafiropoulou R; Papadakis T
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1029-38. PubMed ID: 16894320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is immunoproliferative small intestinal disease uncommon in India?
    Ghoshal UC; Chetri K; Banerjee PK; Choudhuri G; Pal BB; Dabadghao S; Dhar K; Naik S; Naik SR
    Trop Gastroenterol; 2001; 22(1):14-7. PubMed ID: 11398237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
    Nair S; Mathan M; Ramakrishna BS; Mathan VI
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
    Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
    Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Björkholm M; Celsing F; Johansson E;
    Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines.
    Rigacci L; Mappa S; Nassi L; Alterini R; Carrai V; Bernardi F; Bosi A
    Hematol Oncol; 2007 Dec; 25(4):198-203. PubMed ID: 17654614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary cervical epidural low-grade non-hodgkin's lymphoma: a case report and review of the literature].
    Lahiani Ben Salah H; Daoud J
    Cancer Radiother; 2008 Dec; 12(8):863-6. PubMed ID: 18565781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of primary non-Hodgkin's lymphoma of the vagina with chemotherapy.
    Engin H; Türker A; Abali H; Uner A; Günalp S
    Arch Gynecol Obstet; 2004 Mar; 269(3):208-10. PubMed ID: 12904985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
    Zahner J; Kirchner T; Ott G; Schneider W
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.